Itolizumab ELISA Kit

The Structure of Itolizumab ELISA Kit

The Itolizumab ELISA Kit is a diagnostic tool used to detect and quantify the presence of Itolizumab, a monoclonal antibody, in biological samples. The kit is designed for use in research and clinical settings and is based on the principle of enzyme-linked immunosorbent assay (ELISA).

The structure of the Itolizumab ELISA Kit includes several components, each playing a crucial role in the detection and measurement of Itolizumab. These components include:

• Microplate: The microplate is the solid support on which the ELISA reaction takes place. It is typically made of polystyrene and contains multiple wells that can hold the samples and reagents.
• Itolizumab Antibody: The Itolizumab ELISA Kit contains a specific antibody that is designed to bind to Itolizumab. This antibody is immobilized on the surface of the microplate and serves as the capture antibody for the ELISA reaction.
• Itolizumab Standard: The kit also includes a known amount of Itolizumab, which serves as the standard for the ELISA assay. This standard is used to generate a standard curve and determine the concentration of Itolizumab in the samples.
• Enzyme Conjugate: The enzyme conjugate is a secondary antibody that is linked to an enzyme, such as horseradish peroxidase (HRP). This conjugate binds to the captured Itolizumab and serves as a signal for the detection of Itolizumab.
• Substrate Solution: The substrate solution contains a colorless substrate that is converted into a colored product by the enzyme conjugate. This color change is used to measure the amount of Itolizumab in the samples.
• Stop Solution: The stop solution is used to stop the enzyme reaction and prevent further color development. This allows for accurate measurement of the color intensity and subsequent calculation of Itolizumab concentration.

The Activity of Itolizumab ELISA Kit

The Itolizumab ELISA Kit works on the principle of sandwich ELISA, where the Itolizumab in the sample is captured by the immobilized antibody and then detected by the enzyme conjugate. The steps involved in the ELISA assay are as follows:

1. The microplate wells are coated with the Itolizumab antibody, which binds to the Itolizumab present in the samples.
2. The samples, along with the Itolizumab standard, are added to the wells and allowed to incubate. During this time, the Itolizumab in the samples binds to the immobilized antibody.
3. The wells are washed to remove any unbound components, and the enzyme conjugate is added. The conjugate binds to the captured Itolizumab, forming a sandwich complex.
4. The substrate solution is then added, and the enzyme conjugate converts the substrate into a colored product.
5. The stop solution is added to stop the reaction, and the color intensity is measured using a spectrophotometer.

The intensity of the color is directly proportional to the amount of Itolizumab present in the samples. By comparing the color intensity of the samples to that of the standard curve, the concentration of Itolizumab in the samples can be determined.

The Application of Itolizumab ELISA Kit

The Itolizumab ELISA Kit has various applications in research and clinical settings. Some of the key applications include: